TREACE MEDICAL CONCEPTS, INC. Insider Trading Activity

Treace Medical Concepts, Inc. director and Chief Executive Officer John T. Treace reported routine share withholding to cover tax obligations on equity awards.

Accepted by SEC EDGAR 03/11/2026 - 09:00 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Treace Medical Concepts, Inc. director and Chief Executive Officer John T. Treace reported routine share withholding to cover tax obligations on equity awards. On two dates, a total of 7,083 shares of common stock were disposed of as tax-withholding transactions, not open-market sales. After these withholding events, he directly owns 7,004,550 common shares. Footnotes note that certain reported positions include 563,403 and 542,784 restricted stock units and that he disclaims beneficial ownership of shares held by his spouse and in various trusts where he or his spouse serve as trustee or co-trustee.

Insider Trade Summary

Exercise Price or Tax Liability: 7,083 shares

Exercise Price or Tax Liability 2 txns

Insider Treace John T.

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	5,021	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	2,062	$0.00	$0.00
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 7,004,550 shares (Direct); Common Stock — 1,605,000 shares (Indirect, By spouse); Common Stock — 1,471,250 shares (Indirect, By spouse as trustee of a trust); Common Stock — 1,839,063 shares (Indirect, As trustee of a trust); Common Stock — 408,816 shares (Indirect, As co-trustee of a trust)

Holdings Before and After: Common Stock, 7,011,633 to 7,004,550 shares (Direct)

Footnotes (4)

1. F1. Includes 563,403 restricted stock units.
2. F2. Includes 542,784 restricted stock units.
3. F3. The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
4. F4. The Reporting Person disclaims ownership of shares held in trust for which he serves as trustee or co-trustee.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Treace John T.

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FL 32081

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/08/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/08/2026		F		2,062	D	$0	7,009,571(1)	D
Common Stock	03/10/2026		F		5,021	D	$0	7,004,550(2)	D
Common Stock								1,605,000(3)	I	By spouse
Common Stock								1,471,250(3)	I	By spouse as trustee of a trust
Common Stock								1,839,063(4)	I	As trustee of a trust
Common Stock								408,816(4)	I	As co-trustee of a trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 563,403 restricted stock units.

2. Includes 542,784 restricted stock units.

3. The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.

4. The Reporting Person disclaims ownership of shares held in trust for which he serves as trustee or co-trustee.

	/s/ Lisa Taylor as Attorney-in-fact for John Treace	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.